<p><strong>Geriatric</strong>: Dose adjustment in the elderly is not generally necessary. However, for patients of less than 50 kg in body weight, initiate therapy at the lowest recommended dose.<br />
<br />
<strong>Paediatric</strong>: The safety and efficacy of Celecoxib is not established in pediatric patients.<br />
<br />
<strong>Hepatic insufficiency</strong>: Celecoxib capsules should be introduced at a reduced dose in patients with moderate hepatic impairment. The use of Celecoxib in patients with severe hepatic impairment is not recommended.</p>